Cite
APA Citation
Xu, J., Xu, N., Bai, Y., Lin, C., Millward, M., Shi, J., Zhang, Y., Ma, X., Shen, Z., Huang, R., Huang, W., & Shen, L. (n.d.). 79 Tumor-immune signatures associated with response or resistance to tislelizumab (Anti-PD-1) in esophageal squamous cell carcinoma (ESCC). Journal for immunotherapy of cancer, 8, A86. http://access.bl.uk/ark:/81055/vdc_100144732262.0x000005